Cannabinoid receptor activation regulates the release of GABA, the brain’s primary inhibitory neurotransmitter, which plays a crucial role in maintaining neuronal health.
November 1, 2018, was a day for celebration. With one stroke, the British government finally cast aside years of outdated dogma, moving ‘Cannabis Based Medicinal Products’ from Schedule 1 to Schedule 2. Unfortunately, a year has passed and only a handful of patients have actually been prescribed cannabis.